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Intensive home hemodialysis: the best treatment in the
best system
Sir,
With great interest, we read the recently published editorial
comment by Dr Piccoli entitled ‘The never-ending search
for the perfect dialysis. Should we move from the best
treatment to the best system?’ [1].
We are convinced that intensive haemodialysis (HD)
may be the best dialysis treatment in the best system. Not
only in specific circumstances such as pregnancy, after
non-renal solid organ transplantation or in elderly may
intensive home HD be strongly indicated [2, 3], but there
should be an ‘intensive HD first’ strategy at the time
of education of the predialysis patient [4]. Home HD
promotes autonomy and independence and may therefore
further increase quality of life (QoL) in addition to the
multiple benefits of optimized uraemic toxin clearance
and volume control secondary to intensive HD as compared
to other dialysis strategies [2].
Piccoli mentions two potential clinical concerns for
intensive HD. The first refers to the increased risk of
vascular access problems in the context of more frequent
cannulation in intensive HD. The recent FHN trial did
indeed reveal an increased need for vascular access pro-
cedures in the short daily hemodialysis (SDHD) group as
compared to the conventional HD group [5]. However,
the reason for this observation remains unclear as it may
well have been that it was purely due to more frequent
visits to the HD unit with more frequent vascular access
control. The second potential clinical problem mentioned
by Piccoli is the depletion of small molecules and trace
elements and an increased risk of inflammation. However,
excellent phosphate control, improvement of malnutrition
and suppression of inflammation are well-studied advan-
tages of intensive HD and we therefore do not consider
the abovementioned as a potential clinical problem for in-
tensive HD [2].
We support the idea, suggested by Piccoli, of interchan-
geability between different dialysis regimes as long as the
patient follows one of the intensive HD regimes, whether it
is SDHD, alternate night nocturnal HD or nightly nocturnal
HD. Indeed, previous studies have shown that QoL is
higher if patients are provided with the choice of the dial-
ysis modality and it is therefore possible that providing
home HD patients with the autonomy of alternating
between different intensive HD modalities may further
increase QoL.
Finally, it is indeed time now for the governments and
for health care insurance companies to obtain the insight
that end-stage renal disease (ESRD) patients should be
treated with the best treatment in the best system by
changing the reimbursement system. This may enable these
patients to have the highest QoL and physical activity and
thereby also the best social functioning and economic pro-
ductivity. This may further reduce the financial burden of
the treatment of ESRD patients.
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